With the analysis among 122 patents, we discovered top 44 key players by total patent application. Symphony Evolution, Inc., MedImmune LLC, CDG Therapeutics, Inc. are dominant in this area. They take 23.77% of the total patent filing.
Louisiana, United States
Patent: 9
Illinois, United States
Patent: 8
Massachusetts, United States
Patent: 6
Basel-Stadt, Switzerland
Patent: 4
Massachusetts, United States
Patent: 4
California, United States
Patent: 3
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
Gyeonggi-do, South Korea
Patent: 1
With the analysis among related 44 patents applied in the last 5 years. We discover 24 most active companies in this area. The fast-growing The General Hospital Corp., United States of America, China Medical University (Taiwan) take 27.27% of patent filing during this period.
Massachusetts, United States
Patent: 6
China Medical University (Taiwan)
Taiwan Province, China
Patent: 3
North Dakota, United States
Patent: 3
California, United States
Patent: 3
California, United States
Patent: 2
Illinois, United States
Patent: 2
With the analysis among related 44 patents in last 5 years, we discover 19 new entrants. The General Hospital Corp., China Medical University (Taiwan), Sanford Bismarck are the most active new entrants in this area.
Massachusetts, United States
Patent: 6
China Medical University (Taiwan)
Taiwan Province, China
Patent: 3
North Dakota, United States
Patent: 3
California, United States
Patent: 3
With the analysis among 104 patents, we discovered top 26 universities and scientific research institutions by total patent application. Monash University, The University of Queensland, University of Melbourne are dominant in this area. They take 49.04% of the total patent filing.
Victoria, Australia
Patent: 11
Queensland, Australia
Patent: 5
Victoria, Australia
Patent: 3
Vlaams-Brabant, Belgium
Patent: 3
Massachusetts, United States
Patent: 3
China Medical University (Taiwan)
Taiwan Province, China
Patent: 3
New York, United States
Patent: 2